Senior Director of Ethos Science Ethos Veterinary Health Minneapolis, Minnesota, United States
Presentation Description / Summary: Veterinary specialists are regularly asked to evaluate and implement emerging products—from pharmaceuticals and diagnostics to diets and medical devices. Yet the development pathways behind these innovations are often opaque. This session will provide a clear overview of how new veterinary products are conceived, validated, and brought to market. Attendees will gain insight into the scientific, regulatory, and commercial processes involved in product development, including preclinical research, clinical trials, FDA or USDA approval, AAFCO compliance, and post-market monitoring. With a deeper understanding of these pathways, specialists will be better equipped to critically assess new offerings, ask informed questions, and integrate evidence-based solutions into their practice.
Learning Objectives:
Describe the key stages of development for veterinary pharmaceuticals, diagnostics, medical devices, and pet foods, including regulatory and clinical milestones.
Identify the roles of agencies such as FDA-CVM, USDA, and AAFCO in the approval and oversight of new veterinary products.
Evaluate new products more critically by applying knowledge of development pathways, study design, and common marketing practices.
